Form 8-K - Current report:
SEC Accession No. 0001628280-26-048151
Filing Date
2026-07-14
Accepted
2026-07-14 16:05:25
Documents
11
Period of Report
2026-07-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K cbio-20260714.htm   iXBRL 8-K 27357
  Complete submission text file 0001628280-26-048151.txt   142295

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20260714.xsd EX-101.SCH 1800
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20260714_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20260714_pre.xml EX-101.PRE 12520
14 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20260714_htm.xml XML 2716
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 261174325
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)